Juan Morote
Overview
Explore the profile of Juan Morote including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
1904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paesano N, Catala V, Tcholakian L, Alomar X, Barranco M, Hernandez-Mancera J, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941840
Validation of predictive models (PMs) is crucial to be implemented in new populations or when advances in diagnostic approaches occurred. The aim of this study is to validate the BCN-MRI...
2.
Paesano N, Picola N, Munoz-Rodriguez J, Ruiz-Plazas X, Munoz-Rivero M, Celma A, et al.
Diagnostics (Basel)
. 2025 Feb;
15(3).
PMID: 39941218
: A transperineal approach to prostate biopsy is now recommended to reduce the risk of infectious complications associated with the transrectal route. Our aim is to compare the efficacy of...
3.
Esteban L, Borque-Fernando A, Escorihuela M, Esteban-Escano J, Abascal J, Servian P, et al.
Sci Rep
. 2025 Feb;
15(1):4261.
PMID: 39905119
In prostate cancer (PCa), risk calculators have been proposed, relying on clinical parameters and magnetic resonance imaging (MRI) enable early prediction of clinically significant cancer (CsPCa). The prostate imaging-reporting and...
4.
Morote J, Celma A, Semidey M, Antolin A, Miro B, Mendez O, et al.
Cancers (Basel)
. 2025 Jan;
17(1.
PMID: 39796682
Background: Inflammatory features can mimic PCa in suspicious MRI-lesions. Objectives: To assess the incidence of inflammatory features in targeted biopsies to suspicious lesions. Methods: A prospective analysis was conducted of...
5.
Cuadras M, Semidey M, Planas J, de Torres I, Regis L, Celma A, et al.
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769252
Pelvic lymph node dissection (PLND) is the most accurate procedure for lymph node (LN) staging in prostate cancer (PCa) patients. LN sectioning and hematoxylin and eosin (H&E) staining of at...
6.
Morote J, Celma A, Mendez O, Trilla E
BJUI Compass
. 2025 Jan;
5(12):1252-1254.
PMID: 39744069
No abstract available.
7.
Morote J, Paesano N, Picola N, Munoz-Rodriguez J, Ruiz-Plazas X, Munoz-Rivero M, et al.
Life (Basel)
. 2024 Nov;
14(11).
PMID: 39598158
The role of digital rectal examination (DRE) in the early detection of significant prostate cancer (PCa) is being questioned in the era of magnetic resonance imaging (MRI). However, some men...
8.
Paesano N, Vallecillo M, Catala V, Tcholakian L, Alomar X, Barranco M, et al.
Clin Genitourin Cancer
. 2024 Oct;
22(6):102233.
PMID: 39461027
Purpose: Prostate-magnetic resonance imaging (MRI) interpretation is challenging, with expertise playing a crucial role. Biparametric MRI (bpMRI) is gaining popularity in experienced centers due to its time and cost advantages...
9.
Antolin A, Roson N, Mast R, Arce J, Almodovar R, Cortada R, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272809
Early detection of clinically significant prostate cancer (csPCa) has substantially improved with the latest PI-RADS versions. However, there is still an overdiagnosis of indolent lesions (iPCa), and radiomics has emerged...
10.
Toscano-Guerra E, Maggio V, Garcia J, Semidey M, Celma A, Morote J, et al.
Front Oncol
. 2024 Aug;
14:1398411.
PMID: 39193388
Background: Prostate cancer (PCa) is a leading cause of cancer-related deaths in European men, emphasizing the urgent need for effective risk assessment strategies. The TP53 gene, a tumor suppressor gene...